There is no single official number for how much water to drink while taking Farxiga (dapagliflozin), because the FDA labeling intentionally leaves this to your prescriber based on your individual health. What is clear: Farxiga increases your urine output by roughly 250 to 430 mL per day (about 1 to 1.75 extra cups), so most people need to drink more than they did before starting the medication. A reasonable baseline for the average adult is 2 to 3 liters (roughly 8 to 12 cups) of fluid daily, with adjustments depending on your activity level, climate, other medications, and whether you have heart failure or kidney disease.
Why Farxiga Increases Your Fluid Needs
Farxiga works by blocking your kidneys from reabsorbing glucose back into your bloodstream. That extra glucose gets flushed out through your urine, and it pulls water along with it. In clinical studies, people taking dapagliflozin produced about 266 mL more urine per day than those on placebo. That’s roughly the equivalent of an extra glass of water leaving your body every day, on top of your normal output.
This diuretic effect tends to be strongest in the first few weeks of treatment and then levels off somewhat. But the increased urination doesn’t fully disappear, which means your hydration habits need to shift permanently, not just during the adjustment period.
Practical Hydration Targets
For most people taking Farxiga without heart failure or severe kidney problems, aiming for 2 to 3 liters of total fluid per day is a solid starting point. That includes water, tea, coffee, and water-rich foods. If you’re active, live in a hot climate, or sweat heavily, you’ll need more.
A simple tracking method: keep a water bottle with a known volume and refill it throughout the day. If you’re not a natural water drinker, spreading your intake across meals and snacks is easier than trying to catch up all at once. Pale yellow urine is a practical indicator that you’re staying adequately hydrated. Dark yellow or amber-colored urine is a signal to drink more.
If you have recurrent urinary tract infections, which are more common on SGLT2 inhibitors because of the extra sugar in your urine, a multidisciplinary expert consensus recommends pushing fluid intake toward 2 to 3 liters daily. The extra volume helps dilute urine and flush bacteria from the urinary tract.
When More Water Isn’t Always Better
Overhydrating can cause its own problems. For people with heart failure, fluid restrictions are often part of the treatment plan, and drinking extra water could worsen fluid overload, swelling, or breathing difficulty. Farxiga is approved for heart failure, so many people taking it fall into this category. If that’s you, your cardiologist or prescriber should set a specific daily fluid limit that balances dehydration risk against fluid retention.
Even without heart failure, some experts caution against routinely recommending increased fluid intake after starting an SGLT2 inhibitor. The diuretic effect is often transient, and pushing too much fluid can worsen urinary frequency and urgency, which sometimes leads people to stop taking the medication altogether. The goal is adequate hydration, not maximum hydration.
Dehydration and Ketoacidosis Risk
Staying hydrated on Farxiga isn’t just about comfort. Animal research has shown that dehydration is one of the two key triggers for a rare but serious complication called euglycemic ketoacidosis, where your blood becomes dangerously acidic even though your blood sugar looks normal. In lab studies, restoring normal fluid levels prevented ketoacidosis from developing, even when insulin levels remained low. Dehydration drives the process by ramping up stress hormones that accelerate fat breakdown and acid production.
This is why the FDA labeling specifically warns you to contact your prescriber right away if anything reduces your fluid intake or increases fluid loss: vomiting, diarrhea, prolonged sun exposure, illness that kills your appetite, or skipping meals. These are the situations where dehydration and Farxiga can become a dangerous combination.
Who Needs to Be Extra Careful
Certain groups face higher dehydration risk on Farxiga and may need closer monitoring of their fluid balance:
- People taking diuretics. If you’re on a water pill, especially at doses equivalent to more than 40 mg of furosemide per day, the combined fluid loss from both medications raises your risk of volume depletion and kidney injury. Clinical data from the DAPA-HF trial confirmed higher rates of volume depletion when high-dose diuretics were combined with dapagliflozin.
- Older adults. Age-related changes in thirst perception and kidney function make dehydration easier to miss and harder to recover from.
- People with low blood pressure. Farxiga can drop blood pressure further through fluid loss, increasing the chance of dizziness or fainting.
- People on blood pressure medications. ACE inhibitors, ARBs, and NSAIDs can all compound the fluid-depleting effects, raising the risk of acute kidney injury.
For all of these groups, prescribers often check kidney function and hydration status before starting Farxiga and monitor both closely in the early weeks.
Signs You’re Not Drinking Enough
The medication guide for Farxiga lists specific dehydration symptoms to watch for: dizziness, feeling faint, lightheadedness, or weakness, especially when standing up. That last one, called orthostatic hypotension, happens because your blood volume drops low enough that your body can’t maintain normal blood pressure when you change positions.
Other everyday signs include dry mouth, dark urine, headaches, and fatigue. If you notice any of these persistently, increasing your fluid intake by a glass or two per day and tracking whether symptoms improve is a reasonable first step. Symptoms that don’t resolve, or that come with vomiting, diarrhea, or an inability to keep fluids down, need prompt medical attention because they can spiral into more serious complications quickly.
The Initial Kidney Dip
When you first start Farxiga, your kidney filtration rate often drops slightly. This “initial dip,” defined as a decrease of 5 or more points in eGFR within the first two weeks, reflects a deliberate reduction in pressure inside the kidney’s filtering units. It’s generally considered a sign the drug is working as intended and is not the same as kidney damage.
However, if you’re dehydrated when this dip happens, it can become more pronounced and tip into actual kidney injury. This is especially true for people already on multiple medications that affect kidney blood flow. Staying well-hydrated during the first few weeks of Farxiga helps keep this expected dip small and temporary rather than clinically significant.